Public Health Sciences (School of)

Permanent URI for this collectionhttps://uwspace.uwaterloo.ca/handle/10012/9864

This is the collection for the University of Waterloo's School of Public Health Sciences. The School was known as the Department of Public Health and Health Systems until January 2021.

Research outputs are organized by type (eg. Master Thesis, Article, Conference Paper).

Waterloo faculty, students, and staff can contact us or visit the UWSpace guide to learn more about depositing their research.

Browse

Browsing Public Health Sciences (School of) by Author "D'Mello, Kimberly"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    The Use of Vaping Products in Attempts to Stop Smoking: Trends Over Time and Possible Substitution for Other Smoking Cessation Aids in Canada, the United States, England, and Australia
    (University of Waterloo, 2024-09-04) D'Mello, Kimberly
    Background: E-cigarettes are a popular method of smoking cessation assistance. However, few studies have examined whether e-cigarettes serve as a substitute for other effective smoking cessation assistance, including how population-level changes in the use of e-cigarettes for smoking cessation compare to changes in the use of nicotine replacement therapy (NRT), prescription pharmacological therapies, and other smoking cessation methods. Objectives: To examine changes in the types of cessation assistance used by people trying to quit smoking over time, including: 1) the use of e-cigarettes in a quit attempt and 2) the use of other effective methods of cessation assistance. Methods: The study protocol has been preregistered (https://osf.io/jpnqc). Data are from the 2016, 2018, and 2020 Waves of the ITC Four Country Smoking and Vaping Survey. Respondents were recruited by commercial panel firms in each country who were ≥ 18 years of age and, who currently smoke, recently quit smoking, and/or currently vape. Analyses examined the use of cessation assistance among the 14,551 observations from participants with an attempt to quit smoking in the past 12-months since survey date (CA=4,880; US=2,917; EN= 4,846; AU=1,898). Repeat cross-sectional analyses were conducted using generalized estimating equations stratified by country. Results: Across all countries, e-cigarettes (29.9%) and nicotine replacement therapies (NRT; 29.8%) were the most commonly reported categories of cessation assistance used in a previous quit attempt, followed by self–help services (17.8%), and prescription pharmacological therapies (12.6%). Overall, more than half (59.4%) of respondents used ‘any’ form of effective cessation assistance (including e-cigarettes). E-cigarette use increased in Australia from 2016 (11.1%) to 2020 (25.1%; OR=2.29, 95% CI=1.37-3.82, p=.002). In England, e-cigarette use increased from 2016 (37.1%) to 2018 (46.7%; OR=1.40, 95% CI=1.13-1.73, p=.002), and had no changes over time in Canada or the US. Use of other effective cessation methods (with and without e-cigarettes) had no changes over time in all countries, excluding Canada. In Canada, use of ‘any’ form of effective cessation assistance (including e-cigarettes) decreased from 2016 (64.0%) to 2020 (58.9%; OR=0.75, 95% CI=0.61-0.93, p=.010). Conclusion: Overall, there were strikingly similar rates of effective cessation assistance used across all four countries, despite differences in e-cigarette use and regulatory environments. While e-cigarettes are a popular choice of cessation method, there was little evidence that trends in use of e-cigarettes contributed to changes in the use of ‘any’ effective form of cessation assistance. The extent of ‘substitution’ between individual quit methods at the population-level was not directly assessed in this study; however, there was some evidence consistent with substitution for e-cigarettes and use of prescription therapies such that, the use of prescription therapies increased in England as the use of e-cigarettes as a quit method decreased, with the inverse trend in Australia; and little to no changes in the US and Canada.